Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.

Highlights from the Annual Report

UK Renal Registry2013 Annual Audit Meeting

Dr Catriona ShawRegistrar, UK Renal Registry

UK Renal Registry2013 Annual Audit Meeting

The Fifth Edition of the Clinical Practice Guidelines

Module Blood-borne viruses Haemodialysis Vascular Access For Haemodialysis Peritoneal dialysisPeritoneal access Planning, initiation & withdrawal of RRT Assessment of the Potential Kidney Transplant Recipient Acute Kidney Injury Nutrition in CKD Anaemia in CKD Cardiovascular disease in CKD CKD-Mineral and Bone Disorders (CKD-MBD) Detection, Monitoring and Care of Patients with CKD Post-operative Care of the Kidney Transplant Recipient RA and ART Guideline on Water Treatment Facilities, Dialysis Water and Dialysis Fluid Quality for Haemodialysis and Related Therapies

http://www.renal.org/Clinical/GuidelinesSection/Guidelines.aspx

DEMOGRAPHY RRT incidence rates between 1980 and 2011

UK Renal Registry 15th Annual Report

UK Renal Registry 15th Annual Report

Figure 1.6. Median age of incident RRT patients by centre in 2011White points indicate transplant centres

Population aged 65 and over, 2011England and Wales local and unitary authorities

RRT incidence rates in the countriesof the UK 1990–2011

UK Renal Registry 15th Annual Report

UK Renal Registry 15th Annual Report

Figure 1.14. International comparison of RRT incidence rates in 2010Non UK data from USRDS

Prevalence rate of RRT patients per million populationby age and gender on 31/12/2010

Growth in prevalent patients by treatmentmodality at the end of each year 1997–2011

UK Renal Registry 15th Annual Report

MODALITY

UK Renal Registry 15th Annual Report

RRT modality at 90 days(incident cohort 1/10/2010 to 30/09/2011)

UK Renal Registry 15th Annual Report

Figure 2.6. Treatment modality in prevalent RRT patients on31/12/2011

UK Renal Registry 15th Annual Report

Figure 2.7. Treatment modality distribution by age in prevalentRRT patients on 31/12/2011

MULTISITE PERITONEAL DIALYSIS ACCESS CATHETER AUDIT

UK Renal Registry 15th Annual Report

Figure 8.1. Age and gender of PD patients submitted to audit

UK Renal Registry 15th Annual Report

Figure 8.11. Access at first dialysis for centres reporting PD patients, by renal centreBased on 3,867 dialysis patients from centres that reported PD patients. Number of patients at each centre in brackets.

UK Renal Registry 15th Annual Report

Figure 8.12. Referral time from first being seen by renal physician to starting dialysis by type of first access

Based on 3,545 patients from centres that reported PD patients, who had data on both referral time and type of first access. Total number of patients contributing

data to the chart by access type included in x-axis labels (number with missing data in brackets).

UK Renal Registry 15th Annual Report

Figure 9.4. Median time to wait listing for a kidney transplant,by renal centre (centres with <10 patients excluded)

ACCESS TO TRANSPLANTATION

• Starting dialysis in a non-transplanting centre was associated with being less likely to be registered for transplantation (adjusted OR 0.8, 0.74-87)

• After adjustment for age, ethnicity, gender an PRD there were significant centre differences for the probability of being activated on the kidney transplant waiting list and the probability of receiving a renal transplant (all sources)

• ATTOM

ACCESS TO TRANSPLANTATION

UK Renal Registry 15th Annual Report

Figure 4.3. Primary renal disease percentage in incident and prevalent paediatricERF patients in 2011 for whom a causative diagnosis was reported

UK Renal Registry 15th Annual Report

Figure 4.4. Treatment modality at start of RRT by 5 year time period

OPPORTUNITIES

• CKD stage 5 patients to understand conservative and withdrawal issues

• AKI

• RADAR

• Specific need for research focused on improving outcomes in the elderly multi-morbid population (PROMs, PREMs)

VALID REPRODUCIBLE

RELIABLE COMPLETE